Managing Non-acute Subdural Hematoma Using Liquid Materials:a Chinese Randomized Trial of MMA Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
MAGIC-MT study is multi-center, prospective, randomized (1:1) controlled trial designed to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.
Epistemonikos ID: aaa3739a603e82342fa62f3093aaf99d09d4f920
First added on: May 08, 2024